Lonza Biologics has ushered in a new era at its Pease International Tradeport site with a heralded groundbreaking for a new facility. Accompanying it was a less heralded announcement of Chistophe Royer as the new head of site there. The new building is being constructed for Type 1 diabetes researcher Vertex Pharmaceuticals of Boston. The facility will house diabetes cell therapy manufacturing and will be jointly developed by Lonza and Vertex on what is known as the Iron Parcel (because it’s shaped like an iron), one of the last large developable pieces of property at the Tradeport. Source: NH Business Review 30/8/2023